Advanced liver fibrosis, but not MASLD, is associated with accelerated biological aging: a population-based study
Abstract Background The process of biological aging in patients diagnosed with chronic liver disease remains unclear. Aim The current study aims to investigate if there is an accelerated biological aging process in participants with advanced fibrosis (AF) and metabolic dysfunction-associated steatot...
Saved in:
Main Authors: | Chengcheng Tong (Author), Yufeng Xue (Author), Wei Wang (Author), Xi Chen (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD
by: Ang Huang, et al.
Published: (2024) -
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients
by: David Pérez Compte, et al.
Published: (2024) -
Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives
by: Torre E, et al.
Published: (2024) -
Lycorine ameliorates liver steatosis, oxidative stress, ferroptosis and intestinal homeostasis imbalance in MASLD mice
by: Ziwen Wang, et al.
Published: (2024) -
Decreased cobalamin sensitivity and biological aging acceleration in the general population
by: Fan Tang, et al.
Published: (2024)